New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2014
09:10 EDTCHTPChelsea Therapeutics price target raised to $7 from $4 at Roth Capital
Roth Capital increased its price target on Chelsea to reflect a positive recommendation from an FDA panel on the company's Northera drug. The firm keeps a Buy rating on the stock.
News For CHTP From The Last 14 Days
Check below for free stories on CHTP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CHTP

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use